MFN
Drugmakers with White House MFN Deals Claim Exemption from Proposed Medicare Pricing Tests
MFN pricing; Trump administration; Medicare pricing; drug pricing deals; exemptions; pharmaceutical companies
White House unveils nine new “most-favored-nation” drug pricing deals
most-favored-nation pricing; MFN; drug pricing; White House; Trump administration; pharmaceutical manufacturers; Ozempic; Wegovy; Eli Lilly; Novo Nordisk; prescription drug costs; US healthcare policy
Recent News: Live at 11 a.m. ET – M&A, FDA, MFN and Collaboration with FT
M&A; FDA; MFN; Financial Times; mergers and acquisitions; drug approval; economics; live news
Trump Administration Teases MFN Drug Pricing Rule as Commitment Deadline Looms for Companies
Trump administration; Most-Favored-Nation (MFN) pricing; drug pricing; executive order; pharmaceutical manufacturers; Medicaid; direct-to-consumer sales; price parity; commitment deadline; tariffs; international reference price
Tariffs and MFN Policy Power a Broad, Confusing Pharma War
tariffs; Most Favored Nation (MFN) policy; prescription drug pricing; pharmaceutical industry; Trump administration; drug manufacturing; onshoring; Medicaid; pharma innovation
Amid MFN Talks, Lilly Chief Warns US Adoption of International Drug Prices Could Bring ‘Worst of Two Worlds’
Lilly chief; MFN talks; international drug prices; US drug pricing; pharmaceutical industry; policy warning
From deal to disaster: Drugmakers face a changed Washington as Trump embraces most favored nation prices
Prices, Transplant Registry Unified Management Program, MFN, Nation, Disasters, Medicaid, Policy, drugmakers, U.S.